Page last updated: 2024-10-30

meclizine and Multiple Sclerosis

meclizine has been researched along with Multiple Sclerosis in 1 studies

Meclizine: A histamine H1 antagonist used in the treatment of motion sickness, vertigo, and nausea during pregnancy and radiation sickness.

Multiple Sclerosis: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
STERN, FH1

Other Studies

1 other study available for meclizine and Multiple Sclerosis

ArticleYear
COMPARISON OF THREE AGENTS (TIGACOL, DRAMAMINE AND ANTIVERT) FOR THE CONTROL OF DIZZINESS IN GERIATRIC PATIENTS.
    Journal of the American Geriatrics Society, 1963, Volume: 11

    Topics: Alcohols; Benzamides; Cochlear Nerve; Dimenhydrinate; Dizziness; Geriatrics; Humans; Intracranial Ar

1963